Tumor markers in the management of patients with ovarian cancer
- 1 May 1995
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 21 (3) , 215-245
- https://doi.org/10.1016/0305-7372(95)90002-0
Abstract
No abstract availableThis publication has 115 references indexed in Scilit:
- Prospective Multicenter Study on CA 125 in Postmenopausal Pelvic MassesGynecologic Oncology, 1994
- Diagnostic value of pelvic examination, ultrasound, and serum CA 125 in postmenopausal women with a pelvic mass. An international multicenter studyCancer, 1994
- Serum CA 125 concentrations in patients with benign ovarian tumoursJournal of Surgical Oncology, 1994
- Serum CA-125 in the diagnosis of acute pelvic inflammatory diseaseInternational Journal of Gynecology & Obstetrics, 1994
- Tissue polypeptide-specific antigen: A discriminative parameter between prostate cancer and benign prostatic hypertrophyEuropean Journal Of Cancer, 1993
- CA-125 in ovarian cancer: Relation between half-life, doubling time and survivalEuropean Journal of Cancer and Clinical Oncology, 1991
- Early serum CA125 response and outcome in epithelial ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- CA 125 in the diagnosis of pelvic massesEuropean Journal of Cancer and Clinical Oncology, 1989
- CA 125 Serum Levels Correlated With Second-Look Operations Among Ovarian Cancer PatientsObstetrics & Gynecology, 1986
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983